Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MYMX MYMETICS CORPORATION

0.046
+0.008+21.05%
Close 09/28 16:00 ET
High
0.046
Open
0.038
Turnover
880.84
Low
0.038
Pre Close
0.038
Volume
22.00K
Market Cap
13.97M
P/E(TTM)
Loss
52wk High
0.115
Shares
303.76M
P/E(Static)
Loss
52wk Low
0.025
Float Cap
6.40M
Bid/Ask %
0.00%
Historical High
0.120
Shs Float
139.17M
Volume Ratio
0.25
Historical Low
0.025
Dividend TTM
--
Div Yield TTM
--
P/B
-0.23
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.02%
Amplitude
21.69%
Avg Price
0.040
Lot Size
1
Float Cap
6.40M
Bid/Ask %
0.00%
Historical High
0.120
Shs Float
139.17M
Volume Ratio
0.25
Historical Low
0.025
Dividend TTM
--
P/B
-0.23
Dividend LFY
--
Turnover Ratio
0.02%
Amplitude
21.69%
Avg Price
0.040
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Mymetics Corp. operates as a vaccine company. The firm focuses on the research and development of next generation vaccines for infectious and life disabling diseases. It has several vaccine candidates in pipeline: HIV-1/AIDS and Covid-19. Its vaccines for infectious diseases are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense in combination with humoral and cellular immune responses as a second-line defense, which, for some pathogens, may be essential for the development of an effective prophylactic vaccine. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...